William Robinson, MD
Physical Medicine & Rehabilitation · Hickory, NCNPI 1902003361
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 325 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Medtronic at 52.8% of the total. Among physical medicine & rehabilitation clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $24.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$889
- Boston Scientific$759
- Collegium Pharmaceutical, Inc.$388
- Nevro Corp.$339
- Averitas Pharma Inc.$239
- plus $1K from 24 others
What the payments were for
- Travel & lodging$7109%
- Food & beverage$7,29691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 139 | $4,227 |
| Abbott | 15 | $889 |
| Boston Scientific | 31 | $759 |
| Collegium Pharmaceutical, Inc. | 27 | $388 |
| Nevro Corp. | 18 | $339 |
| Averitas Pharma Inc. | 16 | $239 |
| Electronic Waveform Lab, Inc. | 22 | $214 |
| Scilex Pharmaceuticals Inc. | 11 | $160 |
| Vertex | 5 | $107 |
| GRT US Holding, Inc. | 8 | $99 |
| Forte Bio-pharma LLC | 5 | $94 |
| Painteq LLC | 4 | $91 |
| Bioventus LLC | 3 | $57 |
| Pacira Therapeutics, Inc. | 2 | $49 |
| Assertio Therapeutics, Inc. | 4 | $49 |
| AbbVie | 1 | $23 |
| Radius Health, Inc. | 1 | $22 |
| Globus Medical | 1 | $21 |
| Orthofix Medical, Inc. | 1 | $20 |
| Valinor Pharma, LLC | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
| Zimmer Biomet | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| MDD US Operations, LLC | 1 | $13 |
| Arteriocyte Medical Systems, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$491
- INTELLIS ADAPTIVESTIM$360
- Vanta$122
- SPECTRA WAVEWRITER$120
- GENERAL PAIN MANAGEMENT$120
- INCEPTIV$113
How this compares
$8,006 in reported general payments places this provider in the 90th percentile of 269 physical medicine & rehabilitation providers in North Carolina.
See all physical medicine & rehabilitation providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 54 | $54,558 |
| Xtampza ErOxycodone Myristate | 17 | $13,573 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 517 | $13,167 |
| ZtlidoLidocaine | 13 | $12,967 |
| Lidocaine | 88 | $12,589 |
| GraliseGabapentin | 12 | $11,559 |
| Fentanyl | 80 | $10,638 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 312 | $9,721 |
| Oxycodone Hcl | 358 | $7,350 |
| SavellaMilnacipran Hcl | 13 | $6,519 |
| Calcipotriene | 15 | $4,929 |
| MovantikNaloxegol Oxalate | 12 | $4,841 |
| Gabapentin | 316 | $4,027 |
| Pregabalin | 249 | $3,331 |
| Morphine Sulfate ErMorphine Sulfate | 88 | $3,307 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $388 | $13,57317 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $160 | $12,96713 claims |
| Almatica Pharma LLCGralise | $15 | $11,55912 claims |
| AbbVieSavella | $23 | $6,51913 claims |
| Redhill Biopharma Inc.Movantik | $15 | $4,84112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 269 physical medicine & rehabilitation providers in North Carolina.
Other physical medicine & rehabilitation in Hickory
- Graham McRaryHickory$12K
- Jessica UrzenHickory$4K
- Michael McGeheeHickory$3K
- Andrew SumichCharlotte$181K
- Patrick O BrienRaleigh$86K
- Elizabeth BagsbyGreenville$33K
- Krishna BhatSanford$30K
- Jasbir DhaliwalSanford$23K
- Jimmy MaliDurham$20K
- Jerome WatsonStatesville$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.